Anne R Mason

Summary

Affiliation: University of York
Country: UK

Publications

  1. ncbi request reprint Is disease management relevant in Europe: some evidence from the United Kingdom
    A Mason
    Centre for Health Economics, University of York, Heslington, UK
    Health Policy 48:69-77. 1999
  2. ncbi request reprint The effectiveness and cost-effectiveness of respite for caregivers of frail older people
    Anne Mason
    Centre for Health Economics, University of York, York, United Kingdom
    J Am Geriatr Soc 55:290-9. 2007
  3. doi request reprint Public funding of new cancer drugs: Is NICE getting nastier?
    Anne R Mason
    Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO105DD, UK
    Eur J Cancer 45:1188-92. 2009
  4. ncbi request reprint Publishing outcome data: is it an effective approach?
    Anne Mason
    Centre for Health Economics, Alcuin Block A, University of York, York, UK
    J Eval Clin Pract 12:37-48. 2006
  5. pmc Does the English NHS have a 'Health Benefit Basket'?
    Anne Mason
    Centre for Health Economics, University of York, UK
    Eur J Health Econ . 2005
  6. ncbi request reprint Prescribing incentive schemes : a useful approach?
    Anne R Mason
    Centre for Health Economics, University of York, Heslington, York, England
    Appl Health Econ Health Policy 4:111-7. 2005
  7. doi request reprint Should prospective payments be differentiated for public and private healthcare providers?
    Anne Mason
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Health Econ Policy Law 4:383-403. 2009
  8. doi request reprint Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
    Anne Mason
    Centre for Health Economics, University of York, York, United Kingdom
    J Clin Oncol 28:3234-8. 2010
  9. ncbi request reprint Support services for carers of people with mental health problems: building an evidence base to inform policy decisions
    Anne Mason
    Centre for Health Economics, University of York, Heslington, York YO10 5DD, UK
    Appl Health Econ Health Policy 2:37-42. 2003
  10. ncbi request reprint Optometrist prescribing of therapeutic agents: findings of the AESOP survey
    Anne Mason
    Centre for Health Economics, University of York, Heslington, UK
    Health Policy 60:185-97. 2002

Detail Information

Publications17

  1. ncbi request reprint Is disease management relevant in Europe: some evidence from the United Kingdom
    A Mason
    Centre for Health Economics, University of York, Heslington, UK
    Health Policy 48:69-77. 1999
    ..The major perceived barrier to an increase in disease management was NHS suspicion of pharmaceutical companies (86% of all respondents), with the difficulty in drawing up contracts coming a close second (79%)...
  2. ncbi request reprint The effectiveness and cost-effectiveness of respite for caregivers of frail older people
    Anne Mason
    Centre for Health Economics, University of York, York, United Kingdom
    J Am Geriatr Soc 55:290-9. 2007
    ..Given the increasing numbers of frail elderly people and the lack of up-to-date, good-quality evidence for all types of respite care, better-quality evidence is urgently needed to inform current policy and practice...
  3. doi request reprint Public funding of new cancer drugs: Is NICE getting nastier?
    Anne R Mason
    Centre for Health Economics, Alcuin A Block, University of York, Heslington, York YO105DD, UK
    Eur J Cancer 45:1188-92. 2009
    ..The National Institute for Health and Clinical Excellence (NICE) assesses clinical and cost-effectiveness, but recent restrictions on the availability of cancer drugs suggest that NICE may be getting tougher...
  4. ncbi request reprint Publishing outcome data: is it an effective approach?
    Anne Mason
    Centre for Health Economics, Alcuin Block A, University of York, York, UK
    J Eval Clin Pract 12:37-48. 2006
    ..In theory, publication may help to promote public trust, support patient choice, and stimulate action to improve the quality of care whilst controlling costs...
  5. pmc Does the English NHS have a 'Health Benefit Basket'?
    Anne Mason
    Centre for Health Economics, University of York, UK
    Eur J Health Econ . 2005
    ..Regulation may, however, be important in determining citizens' rights. With reference to 'services of curative care', this paper explores whether the NHS is moving towards a more explicit definition of a health basket...
  6. ncbi request reprint Prescribing incentive schemes : a useful approach?
    Anne R Mason
    Centre for Health Economics, University of York, Heslington, York, England
    Appl Health Econ Health Policy 4:111-7. 2005
    ..Our objective was to explore whether schemes might be a useful approach to encourage 'good quality' prescribing...
  7. doi request reprint Should prospective payments be differentiated for public and private healthcare providers?
    Anne Mason
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Health Econ Policy Law 4:383-403. 2009
    ..However, differences in capital costs appear less tractable and further investigation into possible solutions is warranted...
  8. doi request reprint Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric?
    Anne Mason
    Centre for Health Economics, University of York, York, United Kingdom
    J Clin Oncol 28:3234-8. 2010
    ..Coverage decisions that consider cost effectiveness may lead to restrictions in access...
  9. ncbi request reprint Support services for carers of people with mental health problems: building an evidence base to inform policy decisions
    Anne Mason
    Centre for Health Economics, University of York, Heslington, York YO10 5DD, UK
    Appl Health Econ Health Policy 2:37-42. 2003
    ..This paper elucidates issues arising from the study and explores ways towards a more evidence-based future...
  10. ncbi request reprint Optometrist prescribing of therapeutic agents: findings of the AESOP survey
    Anne Mason
    Centre for Health Economics, University of York, Heslington, UK
    Health Policy 60:185-97. 2002
    ..However, adequate comparative research on the performance of optometrists as prescribers is needed and the issue of reimbursement will require careful consideration...
  11. doi request reprint New medicines in primary care: a review of influences on general practitioner prescribing
    A Mason
    Centre for Health Economics, University of York, Heslington, York, UK
    J Clin Pharm Ther 33:1-10. 2008
    ..Focussing on new medicines, this review aimed to explore the determinants of uptake, the causes of geographical variations, and the influence of price, cost and financial incentives on prescribing behaviour...
  12. ncbi request reprint European perspective on the costs and cost-effectiveness of cancer therapies
    Michael F Drummond
    Centre for Health Economics, University of York, York, United Kingdom
    J Clin Oncol 25:191-5. 2007
    ....
  13. pmc Value for money and the Quality and Outcomes Framework in primary care in the UK NHS
    Simon Walker
    Centre for Health Economics, University of York, Heslington, York, UK
    Br J Gen Pract 60:e213-20. 2010
    ..Despite its achievements, there are concerns that the QOF may offer poor value for money...
  14. doi request reprint Topical treatments for chronic plaque psoriasis
    Anne R Mason
    Centre for Health Economics, The University of York, York, UK
    Cochrane Database Syst Rev 3:CD005028. 2013
    ..First-line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid, and topical retinoids...
  15. ncbi request reprint A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carers
    A Mason
    Centre for Health Economics, University of York, UK
    Health Technol Assess 11:1-157, iii. 2007
    ..Where data permitted, subgroups of carers and care recipients, for whom respite care is particularly effective or cost-effective, were to be identified...
  16. ncbi request reprint Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
    J Wilby
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 9:1-157, iii-iv. 2005
    ..To examine the clinical effectiveness, tolerability and cost-effectiveness of gabapentin (GBP), lamotrigine (LTG), levetiracetam (LEV), oxcarbazepine (OXC), tiagabine (TGB), topiramate (TPM) and vigabatrin (VGB) for epilepsy in adults...
  17. ncbi request reprint Medication management in English National Health Service hospitals
    Jonathan Cooke
    Withington Hospital, South Manchester University Hospitals NHS Trust, Nell Lane, West Didsbury, Manchester M20 2LR, United Kingdom
    Am J Health Syst Pharm 62:189-95. 2005
    ..The methods currently used by English National Health Service (NHS) hospitals to manage the use of medicines were studied...